Table 4.
Compound | R1 | R2 | R3 | R4 | Mtb signala (μM) | WS-1b | ||||
---|---|---|---|---|---|---|---|---|---|---|
1.25 | 2.5 | 5 | 10 | 20 | (μM) | |||||
29 | OMe | OMe | OH | A | 1.14 | 1.09 | 1.13 | 1.05 | 0.45 | 16 |
30 | OMe | OMe | OH | B | 1.10 | 1.12 | 1.06 | 0.72 | 0.25 | 2.6 |
31 | OMe | OMe | H | C | 1.21 | 1.10 | 1.11 | 1.07 | 1.02 | 9.7 |
32 | OMe | H | OH | A | 1.11 | 1.17 | 1.14 | 1.28 | 0.95 | 10 |
33 | H | OMe | OH | A | 1.13 | 1.11 | 1.09 | 1.11 | 0.96 | 4.7 |
34 | OMe | OMe | H | D | 0.43 | 0.17 | 0.10 | 0.08 | 0.09 | 5.4 |
Relative luminescence was measured at 3 days after treatment. Values = RLU(sample)/RLU(no compound);
IC50 (mean average n=4), 48 h